anonymous
Guest
anonymous
Guest
How does everyone feel about the future of Fasenra? With no indication for nasal polyps anytime soon (if it even happens) and EOE down the toilet is there a future outside of eosinophilic asthma? It’s unfortunate, because I had such high hopes for this biologic but sadly seems like we will be a niche drug with a very narrow indication. That long runway upper leadership kept touting is getting shorter and shorter.
Dupixent on the other hand will continue to dominate.
Dupixent on the other hand will continue to dominate.